Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice (Q36447954)

14 August 2017

Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice (English)

1 reference

14 August 2017

1 reference

Cristina P Vicente

1

1 reference

14 August 2017

Li He

series ordinal

2

1 reference

14 August 2017

Douglas M Tollefsen

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

18 September 2007

1 reference

14 August 2017

1 reference

14 August 2017

110

1 reference

14 August 2017

13

1 reference

14 August 2017

4261-4267

1 reference

describes a project that uses

14 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC2234791/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stenting

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Thrombin, inflammation, and cardiovascular disease: an epidemiologic perspective

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

A model of primary atherosclerosis and post-angioplasty restenosis in mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Protease-activated receptors in the cardiovascular system

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Inflammation in atherosclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Heparin cofactor II inhibits arterial thrombosis after endothelial injury

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Complete antithrombin deficiency in mice results in embryonic lethality

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Colocalization of thrombin, PAI-1, and vitronectin in the atherosclerotic vessel wall: A potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

The anticoagulant effect of heparan sulfate and dermatan sulfate

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

High plasma heparin cofactor II activity is associated with reduced incidence of in-stent restenosis after percutaneous coronary intervention.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-beta in carotid artery of atherosclerotic rabbits

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Altered vascular injury responses in mice deficient in protease-activated receptor-1.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234791

Activation of heparin cofactor II by fibroblasts and vascular smooth muscle cells

21 September 2018

1 reference

12 December 2020

Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque

1 reference

12 December 2020

Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor ii in the presence of dermatan sulfate but not heparin

1 reference

12 December 2020

Identification of active tissue factor in human coronary atheroma

1 reference

12 December 2020

Comparative metabolism and distribution of rabbit heparin cofactor II and rabbit antithrombin in rabbits

1 reference

12 December 2020

Inhibition of chronic vessel wall intimal hyperplasia following acute anticoagulant treatment: relative effects of heparin and dermatan sulphate

1 reference

12 December 2020

Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice

1 reference

12 December 2020

Pathology of Acute and Chronic Coronary Stenting in Humans

1 reference

12 December 2020

Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II

1 reference

12 December 2020

Heparin cofactor II levels do not predict the development of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study

1 reference

12 December 2020

63 Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone

1 reference

12 December 2020

Activation of heparin cofactor II by dermatan sulfate

1 reference

12 December 2020

Turnover study of heparin cofactor II in healthy man

1 reference

12 December 2020

10.1182/BLOOD-2007-04-086611

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

17878401

1 reference